Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular and plasma thiol-containing nucleophiles comprise a broad class of endogenous molecules characterized by reactive sulfhydryl (-SH) groups, including small molecules like glutathione (GSH) and cysteine, as well as proteins such as human serum albumin. Their primary biological role is the maintenance of redox homeostasis and the protection of cellular components from oxidative stress and electrophilic insult (Townsend et al., 2003, PubMed: 12654468). In pharmacology, these thiols function as a critical detoxification system; for example, glutathione conjugates with the reactive acetaminophen metabolite NAPQI to prevent hepatic necrosis (StatPearls, 2023). However, these nucleophiles also pose a challenge in oncology, as elevated intracellular thiol levels can neutralize electrophilic chemotherapeutic agents like cisplatin before they reach their genomic targets, leading to drug resistance (Kuppusamy et al., 2002, PubMed: 12422171). While not a single therapeutic target, modulating the levels of these thiols—such as using N-acetylcysteine to replenish them or buthionine sulfoximine to deplete them—is a significant strategy in managing toxicity and enhancing drug efficacy (Montero et al., 2018, PubMed: 30149525).
These molecules act as nucleophilic scavengers that undergo covalent conjugation with electrophilic drugs or reactive metabolites, typically mediated by glutathione S-transferases or through spontaneous chemical reaction, leading to drug inactivation and excretion.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and plasma thiol-containing nucleophiles (Thiol nucleophiles).